glioma tissues; paired surrounding normal brain tissues; A172 xenograft tumor tissues
HCN-1a; A172; U251MG; U251; Pri-1; Pri-2; primary human astrocytes; HEK-293 T
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); cell cycle (promotes); mitochondrial function (other); other pathway/process (other)
RT-qPCR; FISH / smFISH; Clinical Sample Validation; Transfection; MTT; EdU Staining; Colony Formation Assay; Transwell Assay; TUNEL; ELISA; Western Blot; In Vivo Animal Model; Bioinformatics Analysis
Potential therapeutic target for glioma treatment
circCSNK1G3 is upregulated in human glioma tissues and glioma cell lines and acts as an oncogenic circRNA. It promotes glioma cell survival, proliferation, migration, invasion and xenograft tumor growth by stabilizing miR-181d and suppressing the tumor-suppressor CBX7. Knockdown of circCSNK1G3 reduces miR-181d, increases CBX7, inhibits tumor growth and activates apoptosis, supporting circCSNK1G3 as a potential therapeutic target.
0.612
A novel nanoplatform-based circCSNK1G3 affects CBX7 protein and promotes glioma cell growth.
combined biological and clinical study